Steven Cohen Dynavax Technologies Corp Transaction History

Point72 Asset Management, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$13.09 - $14.98 $1.86 Million - $2.13 Million	-141,900 Reduced 27.13%	381,200 $5.33 Million
Q3 2023 Nov 14, 2023	BUY	$12.64 - $14.99 $6.61 Million - $7.84 Million	523,100 New	523,100 $7.73 Million
Q1 2020 May 15, 2020	SELL	$2.27 - $6.2 $905,920 - $2.47 Million	-399,084 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.46 - $6.93 $2.04 Million - $4.09 Million	-589,841 Reduced 59.64%	399,084 $2.28 Million
Q3 2019 Nov 15, 2019	BUY	$2.69 - $4.85 $1.17 Million - $2.1 Million	433,925 Added 78.18%	988,925 $3.54 Million
Q2 2019 Aug 14, 2019	BUY	$3.65 - $7.89 $2.03 Million - $4.38 Million	555,000 New	555,000 $2.21 Million
Q4 2018 Feb 14, 2019	SELL	$8.14 - $13.28 $1.2 Million - $1.96 Million	-147,934 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$11.85 - $16.0 $15.5 Million - $20.9 Million	-1,307,100 Reduced 89.83%	147,934 $1.83 Million
Q2 2018 Aug 14, 2018	SELL	$15.15 - $20.75 $54.7 Million - $74.9 Million	-3,608,900 Reduced 71.27%	1,455,034 $22.2 Million
Q1 2018 May 15, 2018	BUY	$14.65 - $19.9 $18.4 Million - $25 Million	1,255,792 Added 32.98%	5,063,934 $101 Million
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $46.7 Million - $65 Million	2,697,514 Added 242.88%	3,808,142 $71.2 Million
Q3 2017 Nov 14, 2017	BUY	$15.2 - $21.5 $16.9 Million - $23.9 Million	1,110,628	1,110,628 $23.9 Million

275

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.62B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.